E-LIB Suche - Ergebnisse für: Zolopa, A.

1

VIH-24 - Analyse intégrée de l'émergence d'une résistance a..:

Demarest, J. ; Quercia, R. ; Zolopa, A....
Médecine et Maladies Infectieuses. 46 (2016) 4 - p. 125-126 , 2016

Link: https://doi.org/10.1016/..

2

Phase I/II study of the pharmacokinetics, safety and antire..:

Markowitz, M. ; Zolopa, A. ; Squires, K....
Journal of Antimicrobial Chemotherapy. 69 (2014) 5 - p. 1362-1369 , 2014

Link: https://doi.org/10.1093/..

3

Elvitegravir/cobicistat/emtricitabine/tenofovir DF (Quad) h..:

Zolopa, A ; Gallant, J ; Cohen, C...
Journal of the International AIDS Society. 15 (2012) S4 - p. 1-1 , 2012

Link: https://doi.org/10.7448/..

4

Resistance after viral failure on atazanavir‐containing the..:

Zolopa, A ; Towner, W ; Lazzarin, A...
Journal of the International AIDS Society. 13 (2010) S4 - p. , 2010

Link: https://doi.org/10.1186/..

5

Pharmacokinetic interactions between indinavir plus ritonav..:

GLESBY, M ; ABERG, J ; KENDALL, M...
Clinical Pharmacology & Therapeutics. 78 (2005) 2 - p. 143-153 , 2005

Link: https://doi.org/10.1016/..

6

Clinical Resistance Patterns and Responses to Two Sequentia..:

Lawrence, J. ; Schapiro, J. ; Winters, M....
The Journal of Infectious Diseases. 179 (1999) 6 - p. 1356-1364 , 1999

Link: https://doi.org/10.1086/..

7

Clinical Resistance Patterns and Responses to Two Sequentia..:

Lawrence, J. ; Schapiro, J. ; Winters, M....
The Journal of Infectious Diseases. 179 (1999) 6 - p. 1356-1364 , 1999

Link: https://www.jstor.org/st..

8

Sex and gender differences in hepatitis C virus risk, preve..:

Levinsson, Anna ; Zolopa, Camille ; Vakili, Farzaneh...
eClinicalMedicine. 72 (2024) - p. 102596 , 2024

Link: https://doi.org/10.1016/..

9

The impact of the COVID-19 pandemic on people who use drugs..:

Mitra, Sanjana ; Bouck, Zachary ; Larney, Sarah...
Harm Reduction Journal. 21 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

10

Expanded Multivariable Models to Assist Patient Selection f..:

Orkin, Chloe ; Schapiro, Jonathan M ; Perno, Carlo F...
Clinical Infectious Diseases. 77 (2023) 10 - p. 1423-1431 , 2023

Link: https://doi.org/10.1093/..

11

Waitlist-controlled trial of an online intervention to addr..:

Berko, Jeff ; Mazonson, Peter ; Short, Duncan...
Antiviral Therapy. 28 (2023) 6 - p. , 2023

Link: https://doi.org/10.1177/..

12

Evaluating Diversity in Randomized Clinical Trials of Dolut..:

Rawlings, M Keith ; Letang, Emilio ; Quercia, Romina...
Open Forum Infectious Diseases. 9 (2022) 8 - p. , 2022

Link: https://doi.org/10.1093/..

13

1284. Suppressed Switch to DTG/3TC 2-Drug Regimen Vs. BIC- ..:

Pierone Jr., Gerald ; Fusco, Jennifer S ; Brunet, Laurence...
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

14

1582. Real-World Use of Long-Acting Cabotegravir + Rilpivir..:

Sension, Michael G ; Hsu, Ricky K ; Fusco, Jennifer S...
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

15

Changes in Youth Mental Health, Psychological Wellbeing, an..:

Zolopa, Camille ; Burack, Jacob A. ; O'Connor, Roisin M....
Adolescent Research Review. 7 (2022) 2 - p. 161-177 , 2022

Link: https://doi.org/10.1007/..